{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:57:17Z","timestamp":1793141837721,"version":"4.5.0"},"reference-count":41,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2023-02622"],"award-info":[{"award-number":["2023-02622"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Early identification of small choroidal melanomas is important, as metastatic risk increases with tumor size. However, distinguishing small melanomas from benign choroidal nevi is challenging and may lead to unnecessary referrals and overtreatment. Both the MOLES scoring system and the deep learning algorithm MelAInoma have been developed to support assessment of pigmented choroidal lesions in non-expert settings. This study aims to compare the association between MOLES and MelAInoma scores and to assess their relative association with expert melanoma versus nevus diagnosis. Methods: In this retrospective cohort study, 86 patients with small pigmented choroidal lesions (29 melanomas and 57 nevi) diagnosed at a national ocular oncology referral center were included. MOLES scores were assigned by ocular oncologists based on multimodal examination, whereas MelAInoma scores were generated solely from color fundus photographs. Associations between scores were assessed using linear regression and the Jonckheere\u2013Terpstra test. Univariable and multivariable binary logistic regression was used to evaluate associations with melanoma diagnosis. Results: MelAInoma scores increased monotonically with higher MOLES categories (p = 0.0001). Linear regression showed a statistically significant association between MOLES and MelAInoma scores, but with substantial dispersion (R2 = 0.16). In univariable logistic regression, both MOLES and MelAInoma scores were associated with increased odds of melanoma diagnosis. MelAInoma showed a stronger association with diagnosis than MOLES (R2 = 0.38 vs. 0.27). In multivariable analysis including both scores, each remained independently associated with melanoma diagnosis. Conclusions: Both MOLES and MelAInoma are effective for differentiating small choroidal melanomas from nevi. Although the scores are statistically associated, they capture partly distinct information. MelAInoma demonstrates slightly stronger association with melanoma diagnosis and provides fully reproducible output, supporting its role as a complementary aid in lesion triage.<\/jats:p>","DOI":"10.3390\/cancers18050818","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:51:33Z","timestamp":1772614293000},"page":"818","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of MOLES and MelAInoma for Differentiating Small Choroidal Melanomas from Nevi"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3187-1752","authenticated-orcid":false,"given":"Katerina","family":"Stripling","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, 171 77 Stockholm, Sweden"},{"name":"St. Erik Eye Hospital, 171 64 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Coud\u00e9 Adam","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, 171 77 Stockholm, Sweden"},{"name":"St. Erik Eye Hospital, 171 64 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Holmstr\u00f6m","sequence":"additional","affiliation":[{"name":"Eyedentity AB, 139 37 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-8911","authenticated-orcid":false,"given":"Gustav","family":"St\u00e5lhammar","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, 171 77 Stockholm, Sweden"},{"name":"St. Erik Eye Hospital, 171 64 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of Uveal Melanoma Millimeter-by-Millimeter in 8033 Consecutive Eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ophtha.2023.10.026","article-title":"Improved Staging of Ciliary Body and Choroidal Melanomas Based on Estimation of Tumor Volume and Competing Risk Analyses","volume":"131","author":"Stalhammar","year":"2023","journal-title":"Ophthalmology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.2012.45.2771","article-title":"Staging of ciliary body and choroidal melanomas based on anatomic extent","volume":"31","author":"Kujala","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hussain, R.N., Coupland, S.E., Kalirai, H., Taktak, A.F.G., Eleuteri, A., Damato, B.E., Groenewald, C., and Heimann, H. (2021). Small High-Risk Uveal Melanomas Have a Lower Mortality Rate. Cancers, 13.","DOI":"10.3390\/cancers13092267"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jamaophthalmol.2014.77","article-title":"Age, survival predictors, and metastatic death in patients with choroidal melanoma: Tentative evidence of a therapeutic effect on survival","volume":"132","author":"Damato","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/24741264251337101","article-title":"Early Treatment in Patients With Small and Medium-Small Class 2 Gene Expression Profiling Uveal Melanoma to Reduce Mortality","volume":"9","author":"Gonzalez","year":"2025","journal-title":"J. VitreoRetin. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archopht.116.5.645","article-title":"Choroidal nevi in a white population: The Blue Mountains Eye Study","volume":"116","author":"Sumich","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.ophtha.2011.05.007","article-title":"Prevalence and characteristics of choroidal nevi: The multi-ethnic study of atherosclerosis","volume":"118","author":"Greenstein","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajo.2019.01.031","article-title":"The Small Fatal Choroidal Melanoma Study. A Survey by the European Ophthalmic Oncology Group","volume":"202","author":"Jouhi","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Prieto-Dominguez, L., Garcia-Alvarez, C., Munoz-Moreno, M.F., Diezhandino, P., Miguel-Perez, D., and Saornil, M.A. (2024). Long Term Follow-Up Observation in Small Choroidal Melanocytic Tumors. Cancers, 16.","DOI":"10.3390\/cancers16152627"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zemba, M., Dumitrescu, O.M., Gheorghe, A.G., Radu, M., Ionescu, M.A., Vatafu, A., and Dinu, V. (2023). Ocular Complications of Radiotherapy in Uveal Melanoma. Cancers, 15.","DOI":"10.3390\/cancers15020333"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.preteyeres.2018.03.004","article-title":"Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death\u2014A personal view","volume":"66","author":"Damato","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ophtha.2023.11.021","article-title":"Delays between Uveal Melanoma Diagnosis and Treatment Increase the Risk of Metastatic Death","volume":"131","author":"Stalhammar","year":"2024","journal-title":"Ophthalmology"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Moghadam, A., Gill, V.T., Sabazade, S., Hagstrom, A., and Stalhammar, G. (2026). Independent validation of time to treatment as a prognostic factor in uveal melanoma. BMC Cancer, 26.","DOI":"10.1186\/s12885-026-15775-z"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/tvst.14.6.29","article-title":"Challenges for Opticians in Evaluating Small Pigmented Choroidal Lesions: Potential Support From the MelAInoma Deep Learning Algorithm","volume":"14","author":"Sabazade","year":"2025","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/bjophthalmol-2018-312967","article-title":"Combination of multimodal imaging features predictive of choroidal nevus transformation into melanoma","volume":"103","author":"Dalvin","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Obuchowska, I., and Konopinska, J. (2022). Importance of Optical Coherence Tomography and Optical Coherence Tomography Angiography in the Imaging and Differentiation of Choroidal Melanoma: A Review. Cancers, 14.","DOI":"10.3390\/cancers14143354"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/opo.12413","article-title":"The advantages of intermediate-tier, inter-optometric referral of low risk pigmented lesions","volume":"37","author":"Ly","year":"2017","journal-title":"Ophthalmic Physiol. Opt."},{"key":"ref_19","first-page":"100613","article-title":"Development and Validation of a Deep Learning Algorithm for Differentiation of Choroidal Nevi from Small Melanoma in Fundus Photographs","volume":"4","author":"Sabazade","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000511363","article-title":"Distinguishing Choroidal Nevi from Melanomas Using the MOLES Algorithm: Evaluation in an Ocular Nevus Clinic","volume":"7","author":"Sagoo","year":"2021","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Roelofs, K.A., O\u2019Day, R., Harby, L.A., Arora, A.K., Cohen, V.M.L., Sagoo, M.S., and Damato, B. (2020). The MOLES System for Planning Management of Melanocytic Choroidal Tumors: Is It Safe?. Cancers, 12.","DOI":"10.3390\/cancers12051311"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"28534","DOI":"10.1038\/s41598-024-78692-w","article-title":"Performance of the MOLES and TFSOM-DIM scores in classifying choroidal nevi and melanoma","volume":"14","author":"Jahnke","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41433-022-02143-x","article-title":"Can the MOLES acronym and scoring system improve the management of patients with melanocytic choroidal tumours?","volume":"37","author":"Damato","year":"2023","journal-title":"Eye"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/08164622.2022.2029685","article-title":"The MOLES system to guide the management of melanocytic choroidal tumours: Can optometrists apply it?","volume":"106","author":"Flanagan","year":"2023","journal-title":"Clin. Exp. Optom."},{"key":"ref_25","first-page":"259","article-title":"Risk factors for growth and metastasis of small choroidal melanocytic lesions","volume":"93","author":"Shields","year":"1995","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archophthalmol.2009.151","article-title":"Choroidal nevus transformation into melanoma: Analysis of 2514 consecutive cases","volume":"127","author":"Shields","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archopht.118.3.360","article-title":"Combination of clinical factors predictive of growth of small choroidal melanocytic tumors","volume":"118","author":"Shields","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.survophthal.2024.09.004","article-title":"Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis","volume":"70","author":"Stalhammar","year":"2025","journal-title":"Surv. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/OPX.0000000000002256","article-title":"Survey of Australian primary eyecare management of choroidal nevus patients","volume":"102","author":"Conway","year":"2025","journal-title":"Optom. Vis. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/s41433-022-02110-6","article-title":"Survey of ophthalmic imaging use to assess risk of progression of choroidal nevus to melanoma","volume":"37","author":"DeSimone","year":"2023","journal-title":"Eye"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100167","DOI":"10.1016\/j.ajoint.2025.100167","article-title":"Development of a deep learning model to classify choroidal melanoma risk factors based on color fundus photographs","volume":"2","author":"Suri","year":"2025","journal-title":"AJO Int."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Roelofs, K.A., O\u2019Day, R., Al Harby, L., Hay, G., Arora, A.K., Cohen, V.M.L., Sagoo, M.S., and Damato, B.E. (2020). Detecting Progression of Melanocytic Choroidal Tumors by Sequential Imaging: Is Ultrasonography Necessary?. Cancers, 12.","DOI":"10.3390\/cancers12071856"},{"key":"ref_33","first-page":"e191","article-title":"Metastatic potential of small posterior uveal melanomas","volume":"104","author":"Stalhammar","year":"2025","journal-title":"Acta Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000518868","article-title":"A Word of Caution regarding Risk Factors for Malignant Transformation of Choroidal Nevi","volume":"7","author":"Stalhammar","year":"2021","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1167\/iovs.64.13.45","article-title":"Rotterdam Ocular Melanoma Study Group. Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors","volume":"64","author":"Wu","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"612.e1","DOI":"10.1016\/j.ajo.2005.05.034","article-title":"Population-based incidence of uveal melanoma in various races and ethnic groups","volume":"140","author":"Hu","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clindermatol.2023.10.012","article-title":"Understanding choroidal nevus risk factors for transformation into melanoma","volume":"42","author":"DeSimone","year":"2024","journal-title":"Clin. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1097\/01.CCM.0000275267.64078.B0","article-title":"Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited","volume":"35","author":"Kramer","year":"2007","journal-title":"Crit. Care Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/5\/818\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T09:05:40Z","timestamp":1772615140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/5\/818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cancers18050818"],"URL":"https:\/\/doi.org\/10.3390\/cancers18050818","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]}}}